GOLTEN ALEX S

GS Chief Risk Officer Alex Golten sold 1.1K shares for $1.0M at blended $919.19; holds 3.7K shares post-transaction.

Alex Golten, Chief Risk Officer at Goldman Sachs, executed 2 separate sales totaling 1,115 shares for $1,024,894.80 at an average price of $919.19 on April 17, 2026, reducing his holdings by 23.2% to 3,694 shares. His cross-ticker track record shows a 90-day well-timed rate of 100.00% across 7 prior sells (avg 90d return −14.1%), though at GS specifically, his 5 prior trades in February 2026 showed consistent negative 30-day returns (−11.7% to −12.2%) with no measurable 90-day outcomes yet. The stock currently trades at $926.55, near its 52-week high of $975.86, having gained 13.9% over 30 days despite the insider's sale. The CRO's discretionary liquidation of a material stake warrants monitoring given his formal risk oversight role, though the lack of measurable pattern at this specific ticker limits inference about forward guidance.

Goldman Sachs CRO Alex Golten sells entire 2,292-share stake for $2,143,044.67 on 2026-02-09

Alex Golten, Chief Risk Officer of Goldman Sachs Group Inc, executed 5 separate sales on 2026-02-09 totaling 2,292 shares (2.3K shares) for $2,143,044.67 ($2.1M), reducing his holdings to zero post-transaction. The blended average price across the five transactions was $935.01, just 1.0% below the current price of $944.59. Across his cross-ticker track record, Golten's 2 prior sells averaged a 90-day return of -14.1% with a 100.00% well-timed rate, and his 2 prior trades at Goldman Sachs (both on 2025-01-28) exhibited 90-day declines of -14.0% and -14.2%—establishing a historical pattern of selling before subsequent downturns. However, the current 30-day and 90-day price changes at GS are -0.5% and +17.3% respectively, suggesting the stock has not yet replicated the pattern observed in his prior two insider sales at this ticker.

GS Chief Risk Officer sells 5,208 shares for $3.3M at $636.25, reducing holdings by 59.5%

Alex S Golten, GS Chief Risk Officer, executed 2 separate sales on 2025-01-28 totaling 5,208 shares for $3,313,567.12 at an average price of $636.25. This sale reduced his post-transaction holdings to 3,545 shares, representing a 59.5% reduction in his stake. The current stock price of $645.70 is at the 52-week high, and the stock has appreciated 12.8% over 30 days and 24.3% over 90 days, indicating strong recent momentum at the time of the sale. A substantial reduction in holdings by a Chief Risk Officer during a period of elevated stock valuation warrants investor attention to understand the business rationale underlying the divestiture.